Given the major role of HIF-1α in compensating for oxygen deficiency by increasing availability of oxygen or providing metabolic adaptation of tumor cells, the inhibition of this activity might provide a potential approach to FMGC treatments. The gene discussed is HIF1A; the disease is neoplasm.